UBS Group’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

UBS Group’s Portfolio EQHA.U Stock Details EQHA.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,598	Closed	-$26K	–	10100
2021 Q1	$26K	Buy	+2,598	New	+$26.4K	﹤0.01%	7148

Other funds holding EQHA.U

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Inherent Group New York $108M AUM 55.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

UBS Group's EQHA.U Position: Q2 2021 in Review

UBS Group sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q2 2021, closing a stake of 2,598 shares — an estimated $26K sold.

UBS Group first reported a position in EQHA.U in Q1 2021 and held it in 1 quarter. The position peaked at $26K in Q1 2021. 43 funds tracked by Wall St. Rank hold EQHA.U as of Q2 2021.

UBS Group reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
UBS Group sold 2,598 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q2 2021, an estimated $26K.
UBS Group first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 1 quarter.
UBS Group's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $26K in Q1 2021.
43 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.